
May 9, 2026
NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration
NVIDIA is advancing its influence in drug development through a new partnership with Simulations Plus, leveraging GPU acceleration and AI-assisted workflows.This collaboration aims to enhance complex modeling and simulation tasks critical for early-stage drug discovery and development. By integrating NVIDIA's powerful GPUs into the drug research process, the partnership seeks to improve efficiencies in quantitative systems pharmacology and physiologically based pharmacokinetics. This strategic m